APLEX Bio’s multiplex solution radically disrupts current molecular detecting models, identifying such a vast number of different pathogens in just one test. EQT Foundation finds the technology most interesting as this enables access to reliable diagnostic testing in a cost-effective way, giving doctors the possibility to achieve highly parallelized detection of biomarkers in a new, easy way. In for example low-resource settings, where individual testing is not possible, there is great potential to serve underserved groups globally, using for example wastewater-based epidemiology to monitor public health in an efficient and cost-effective way.